Class II transactivator knockdown limits major histocompatibility complex II expression, diminishes immune rejection, and improves survival of allogeneic bone marrow stem cells in the infarcted heart

Use of Mesenchymal Stem Cells for Therapy of Cardiac Disease

(2015) V. Karantalis et al.   CIRCULATION RESEARCH

Does Transendocardial Injection of Mesenchymal Stem Cells Improve Myocardial Function Locally or Globally?

(2014) Viky Y. Suncion et al.   CIRCULATION RESEARCH

Cell Therapy for Heart Failure

(2013) Santosh K. Sanganalmath et al.   CIRCULATION RESEARCH

Autologous and allogeneic mesenchymal stem cells in organ transplantation

(2013) Senthilkumar Alagesan et al.   Current Opinion in Organ Transplantation

Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy

(2012) Joshua M. Hare et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pluripotent Stem Cells: Immune to the Immune System?

(2012) J. I. Pearl et al.   Science Translational Medicine

Challenges in Allogeneic Mesenchymal Stem Cell–Mediated Cardiac Repair

(2012) Sanjiv Dhingra et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Manifestations and mechanisms of stem cell aging

(2011) Ling Liu et al.   JOURNAL OF CELL BIOLOGY

Heart regeneration

(2011) Michael A. Laflamme et al.   NATURE

Differentiation of Allogeneic Mesenchymal Stem Cells Induces Immunogenicity and Limits Their Long-Term Benefits for Myocardial Repair

(2010) Xi-Ping Huang et al.   CIRCULATION

Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery

(2009) Shu-Hong Li et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide

(2008) Guangwen Ren et al.   Cell Stem Cell